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Quantifying and understanding the effects of HIV infection and antiretroviral treatment (ART) on 
fertility is essential for accurate global and national HIV estimates – and especially for estimates of key 
indicators of the HIV epidemic in children including coverage of prevention of mother-to-child 
transmission (PMTCT) and paediatric treatment programmes, the contribution of long-term survival 
from mother-to-child transmission to HIV prevalence at adolescent and young adult ages, and the 
growing numbers of HIV-exposed uninfected children, for whom, exposure to certain ART drugs at 
conception may increase the risk of neural tube defects1. Equally – if not more – important, this 
information is needed to ensure that women on ART get appropriate counselling and access to family 
planning and sexual health services. 
Prior to ART, lower fertility in HIV-positive women in sub-Saharan Africa was well-documented2-5. The 
relationship between HIV and fertility varied with age – in the youngest age-group (15-19 years), 
fertility was higher among HIV-positive women, due to selection of sexually-active women, while, at 
older ages (25 years and above), the fertility of HIV-positive women became progressively lower than 
that of their uninfected counterparts. Biological and socio-behavioural mechanisms were 
hypothesised to explain HIV subfertility. Biological factors included the physiological and 
immunological effects of HIV infection, coinfections with other STIs, and lower semen quality in male 
HIV-infected partners6-8. Socio-behavioural factors included reduced sexual activity in HIV-positive 
women compared to HIV-negative women due to poor health, greater widowhood and marital 
dissolution, and low rates of remarriage9-11. 
It had been widely anticipated that ART scale-up would attenuate many of these mechanisms; thereby 
lessening subfertility in HIV-positive women12. For example, the physiological and immunological 
effects of HIV in lowering fertility could be reduced if ART lessens the progression and severity of 
women’s HIV disease. Reduced widowhood and divorce, together with increased sexual activity due 
to improved health, could increase exposure to pregnancy for HIV-positive women compared to the 
pre-ART era. Fertility desires might also change. However, a systematic review by Yeatman and 
colleagues13, which examined data collected largely during periods of ART scale-up, found a mixed 
picture and concluded that fertility in HIV-positive women may increase after the first year on ART but 
remains lower than in HIV-negative women of the same age. 
In this issue of the Journal of Infectious Diseases, Johnson and colleagues14 employ novel methods to 
compile and analyse a large dataset drawn from routine programme records in the Western Cape in 
South Africa to provide further insight into the impact of ART on fertility. Using South Africa’s unique 
patient identifier, they linked data from women’s antenatal care visits with data on HIV status and 
ART. For women with evidence of at least one pregnancy, they used time from date of first pregnancy 
outcome to date of second pregnancy conception to compare pregnancy rates by HIV infection and 
ART status. Consistent with the studies conducted in the pre-ART period, the authors found that 
pregnancy rates in HIV-positive women not on ART were lower than in HIV-negative women. However, 
they also found that pregnancy rates in HIV-positive women on ART were higher than those in HIV-
negative women.  
The new study is important in that it strengthens the evidence that, among women with a recent 
pregnancy, the subsequent pregnancy rate in women on ART is higher than the rate for infected but 
ART naïve women; and adds to the literature a finding that, in this population, their pregnancy rate 
also exceeds that in uninfected women. Unfortunately, however, key questions remain regarding 
fertility differentials in women who do not have a recent history of pregnancy and, therefore, about 
the generalisability of the study findings to women as a whole in the population. Included in the 
Yeatman review, the only clinic-based studies which yielded a similar finding that, among HIV-positive 
women, women on ART had higher pregnancy rates than those who were ART-naïve, were also from 
populations of women who were recently pregnant15 or pregnant at enrolment16. The second of these 
studies found no such difference in pregnancy rates for HIV-positive women who were not pregnant 
at enrolment16. In one of two population-based studies17, a higher incidence of pregnancies was found 
in HIV-positive women on ART compared to those who were ART-naïve; but, women not at risk of 
pregnancy, including those using hormonal contraceptives were excluded from the analysis which may 
have resulted in selection bias. In the second population-based study, no difference was found 
between HIV-positive women on ART compared to those who were ART-naïve18. These studies, 
therefore, taken together with the new study in South Africa, appear to show that ART raises fertility 
in HIV-positive women who have recently been pregnant – and thereby have demonstrated that they 
are already fecund despite being infected – but that ART has little or no impact on fertility for those 
who have not been pregnant recently. 
For HIV-positive women who have had a recent pregnancy, as in other studies15, 16, Johnson and 
colleagues found that pregnancy incidence rates were higher in women on ART than in ART naïve 
women even after controlling for CD4 count. This suggests that there are mechanisms independent of 
physiological improvements in health that contribute to increased pregnancy incidence. The authors 
point to reasons such as increased fertility desires or increased motivation to start ART in women who 
want further children. Another possibility is that ART may lower the efficacy of some hormonal 
contraceptives19 which are used by 31% of women in the Western Cape20. Currently, it is unknown 
whether the high pregnancy rate in HIV-positive women on ART compared to uninfected women will 
continue or whether this is a tempo effect such that completed family size will eventually be the same 
in the two groups. 
For HIV-positive women who have not had a recent pregnancy, there are a number of mechanisms 
that could limit the effect of ART in reversing HIV-associated subfertility. These include that these 
women may have no sexual partner, may be using condoms or other effective forms of contraception, 
or may be infertile – perhaps due to a history of other STIs such as Gonorrhoea or Chlamydia21. 
The impact of ART on fertility at the population level will be a combination of its impact on the fertility 
of HIV-positive women who have and have not had recent pregnancies. Whilst Johnson and colleagues 
provide evidence that ART increases fertility in women who have recently been pregnant, once women 
who have not recently had a child or who have never been pregnant are included, the difference in 
fertility between women on ART and HIV-negative women may disappear or be reversed. The end 
result may also depend on the composition of the population on ART in terms of how they enrol into 
care (via antenatal or counselling and testing services) and overall ART coverage.  
A number of vital pieces of the jigsaw therefore remain missing for modelling the population-level 
effects of ART on fertility and providing reliable estimates of the impact of HIV, PMTCT and ART on 
children. In addition to the above, further pieces that remain poorly understood include the 
possibilities that: 1) initially ART scale-up may increase the fertility of women who are not yet on 
treatment – in absolute terms and relative to that of HIV-negative women – due to selective initiation 
on ART of women at more advanced stages of infection; 2) changes in policy over time can change the 
population on ART; for example, the change in WHO guidelines to option B+, where women are 
immediately offered treatment for life regardless of their CD4 count,  may have increased the 
proportion of healthier, recently-pregnant women on ART; 3) the impact of ART may vary by region 
due to differences in the underlying reasons for HIV subfertility; and 4) ART scale-up may have indirect 
effects on the fertility of HIV-negative women – for example, through its effects in reducing HIV 
transmission and in increasing risk compensation and unprotected sex. 
The most effective way to fill in these missing pieces of the puzzle and build on the study by Johnson 
and colleagues could be to collect and analyse more data in prospective general population HIV sero-
surveys, as has been done in Zimbabwe and Malawi18, 22 and may be possible in other studies in the 
ALPHA network23 particularly those with links to routine data from local CTC clinics. This would allow 
further comparisons of fertility rates between HIV-positive women – by HIV diagnosis and ART status 
– and uninfected women, investigation of potential mechanisms of ART impact in these groups, and 
evaluation of the biases inherent in analyses of clinic-based data. Data from CTC clinics could  provide 
reliable information on patterns and trends in the composition of women on ART (by age, CD4 count, 
pregnancy status at initiation) and on how these women were referred for initiation. This could also 
help us to understand the reasons for observed fertility differences (or lack of differences) between 
women on and off ART, and to infer how the population not seen at CTC clinics might be changing. 
Networks such as the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network24, an 
international collaboration between CTC clinics including clinics in sub-Saharan Africa, are ideally 
placed to look at such data.   
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